<?xml version="1.0" encoding="UTF-8"?>
<p id="Par70">The uncertain effects of RAAS blockers on ACE2 levels and activity in humans has led to an alternative hypothesis that ACE2 may be beneficial rather than harmful in patients with lung injury. Furthermore, this hypothesis raises the concern that withdrawal of RAAS inhibitors may be harmful in certain high-risk patients with known or suspected COVID-19 [
 <xref ref-type="bibr" rid="CR64">64</xref>].
</p>
